Eric Sommers

575 total citations
19 papers, 468 citations indexed

About

Eric Sommers is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Eric Sommers has authored 19 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Eric Sommers's work include Lung Cancer Treatments and Mutations (10 papers), Lung Cancer Diagnosis and Treatment (8 papers) and Radiomics and Machine Learning in Medical Imaging (3 papers). Eric Sommers is often cited by papers focused on Lung Cancer Treatments and Mutations (10 papers), Lung Cancer Diagnosis and Treatment (8 papers) and Radiomics and Machine Learning in Medical Imaging (3 papers). Eric Sommers collaborates with scholars based in United States, Spain and South Korea. Eric Sommers's co-authors include Gerold Bepler, Lary A. Robinson, Eric B. Haura, Alan Cantor, Anupama Sharma, Ashish Gautam, George R. Simon, Swati Sharma, David Boulware and Zhong Zheng and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and CHEST Journal.

In The Last Decade

Eric Sommers

18 papers receiving 454 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Sommers United States 10 310 236 164 102 53 19 468
Mar Abad Spain 11 121 0.4× 172 0.7× 221 1.3× 57 0.6× 82 1.5× 25 483
Jane Bromund United States 9 467 1.5× 447 1.9× 127 0.8× 85 0.8× 42 0.8× 17 609
Claudio Sini Italy 15 227 0.7× 235 1.0× 163 1.0× 128 1.3× 29 0.5× 28 440
See‐Chun Phan United States 11 249 0.8× 303 1.3× 89 0.5× 65 0.6× 66 1.2× 17 435
Shoji Nakata Japan 12 227 0.7× 287 1.2× 271 1.7× 84 0.8× 67 1.3× 26 614
Roberta Bartolucci Italy 10 285 0.9× 315 1.3× 171 1.0× 105 1.0× 47 0.9× 17 532
Alberto Cambieri Italy 6 512 1.7× 470 2.0× 336 2.0× 195 1.9× 75 1.4× 6 790
R. Rosell Spain 8 407 1.3× 376 1.6× 143 0.9× 83 0.8× 73 1.4× 21 612
Norihiro Yamaguchi United States 6 312 1.0× 233 1.0× 156 1.0× 149 1.5× 14 0.3× 7 451
Wendy Tsui Australia 6 125 0.4× 286 1.2× 199 1.2× 85 0.8× 31 0.6× 6 544

Countries citing papers authored by Eric Sommers

Since Specialization
Citations

This map shows the geographic impact of Eric Sommers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Sommers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Sommers more than expected).

Fields of papers citing papers by Eric Sommers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Sommers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Sommers. The network helps show where Eric Sommers may publish in the future.

Co-authorship network of co-authors of Eric Sommers

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Sommers. A scholar is included among the top collaborators of Eric Sommers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Sommers. Eric Sommers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Haura, Eric B., et al.. (2010). A Pilot Study of Preoperative Gefitinib for Early-Stage Lung Cancer to Assess Intratumor Drug Concentration and Pathways Mediating Primary Resistance. Journal of Thoracic Oncology. 5(11). 1806–1814. 47 indexed citations
3.
Gray, Jhanelle E., Eric Sommers, Miguel Alvelo‐Rivera, Lary A. Robinson, & Gerold Bepler. (2009). Neoadjuvant chemotherapy for resectable non-small-cell lung cancer.. PubMed. 23(10). 879–86. 1 indexed citations
4.
Tanvetyanon, Tawee, Lary A. Robinson, Eric Sommers, et al.. (2009). Survival predictors after surgical resection of synchronous bilateral non-small cell lung cancers (NSCLC). Journal of Clinical Oncology. 27(15_suppl). 7517–7517. 1 indexed citations
5.
Zheng, Zhong, Xueli Li, Michael J. Schell, et al.. (2008). Thymidylate synthase in situ protein expression and survival in stage I nonsmall‐cell lung cancer. Cancer. 112(12). 2765–2773. 54 indexed citations
6.
Tanvetyanon, Tawee, Edward A. Eikman, Eric Sommers, et al.. (2008). Computed Tomography Response, But Not Positron Emission Tomography Scan Response, Predicts Survival After Neoadjuvant Chemotherapy for Resectable Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 26(28). 4610–4616. 48 indexed citations
7.
Sommers, Eric, et al.. (2008). Posterior midline approach for single-stage en bloc resection and circumferential spinal stabilization for locally advanced Pancoast tumors. Journal of Neurosurgery Spine. 9(1). 71–82. 13 indexed citations
8.
Haura, Eric B., et al.. (2007). Pilot phase II study of preoperative gefitinib in early stage non-small cell lung cancer with assessment of intratumor gefitinib levels and tumor target modulation. Journal of Clinical Oncology. 25(18_suppl). 7603–7603. 11 indexed citations
9.
Ramnath, Nithya, Eric Sommers, Lary A. Robinson, et al.. (2005). Phase II Study of Neoadjuvant Chemotherapy With Gemcitabine and Vinorelbine in Resectable Non-small Cell Lung Cancer. CHEST Journal. 128(5). 3467–3474. 17 indexed citations
10.
Bepler, Gerold, Eric Sommers, Lary A. Robinson, et al.. (2005). O-111 Neoadjuvant gemcitabine and pemetrexed (NeoGP) in resectable non-small-cell lung cancer (NSCLC). Lung Cancer. 49. S39–S39. 2 indexed citations
11.
Ramnath, Nithya, Eric Sommers, Lary A. Robinson, et al.. (2005). Phase II study of neoadjuvant chemotherapy with gemcitabine and vinorelbine in resectable non-small-cell lung cancer (NSCLC). Journal of Clinical Oncology. 23(16_suppl). 7277–7277. 1 indexed citations
12.
Bepler, Gerold, Swati Sharma, Alan Cantor, et al.. (2004). RRM1 and PTEN As Prognostic Parameters for Overall and Disease-Free Survival in Patients With Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 22(10). 1878–1885. 154 indexed citations
13.
Bepler, Gerold, Zhong Zheng, Ashish Gautam, et al.. (2004). Ribonucleotide reductase M1 gene promoter activity, polymorphisms, population frequencies, and clinical relevance. Lung Cancer. 47(2). 183–192. 68 indexed citations
14.
Bepler, Gerold, Shivani Sharma, Alan Cantor, et al.. (2004). Validation of RRM1 and PTEN as prognostic parameters of outcome in non-small cell lung cancer. Journal of Clinical Oncology. 22(14_suppl). 7154–7154. 1 indexed citations
15.
Bepler, Gerold, Shivani Sharma, Alan Cantor, et al.. (2004). Validation of RRM1 and PTEN as prognostic parameters of outcome in non-small cell lung cancer. Journal of Clinical Oncology. 22(14_suppl). 7154–7154. 1 indexed citations
16.
17.
Simon, George R., John C. Ruckdeschel, Charles C. Williams, et al.. (2003). Gefitinib (ZD1839) in Previously Treated Advanced Non-Small-Cell Lung Cancer: Experience from a Single Institution. Cancer Control. 10(5). 388–395. 30 indexed citations
18.
Tockman, Melvyn S., Todd R. Hazelton, Lynn Coppage, et al.. (2003). O-129 Lung cancer screening with helical CT: Evidence for a stage shift?. Lung Cancer. 41. S40–S41. 3 indexed citations
19.
Smith, Lewis J., Eric Sommers, Carl E. Hunt, & Lauren M. Pachman. (1986). Hyperoxic lung injury in mice: a possible protective role for prostacyclin.. PubMed. 108(5). 479–88. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mar Abad Breakdown of academic impact, for papers by Jane Bromund Breakdown of academic impact, for papers by Claudio Sini Breakdown of academic impact, for papers by See‐Chun Phan Breakdown of academic impact, for papers by Shoji Nakata Breakdown of academic impact, for papers by Roberta Bartolucci Breakdown of academic impact, for papers by Alberto Cambieri Breakdown of academic impact, for papers by R. Rosell Breakdown of academic impact, for papers by Norihiro Yamaguchi Breakdown of academic impact, for papers by Wendy Tsui
Rankless by CCL
2026